# Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combination-of-chemotherapy-and-gefitinib-as-first-line-treatment-for-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Baohui Han,Bo Jin,Tianqing Chu,Yanjie Niu,Yu Dong,Jianlin Xu,Aiqing Gu,Hua Zhong,Huimin Wang,Xueyan Zhang,Chunlei Shi,Yanwei Zhang,Wei Zhang,Yuqing Lou,Lei Zhu,Jun Pei |
| Citations | 153 |
| DOI | 10.1002/ijc.30806 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.30806 |
| OpenAlex ID | https://openalex.org/W2619919786 |
| PMID | 28560853 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Jianlin Xu](https://scholariq.org/researchers/jianlin-xu/)

## Paper journal

- [International Journal of Cancer](https://scholariq.org/journals/international-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.